FRANCE BED HOLDINGS CO.,LTD. FY2027 Q1 Earnings Report

Financial Highlights

• Net Sales: ¥14.97B
• Operating Income: ¥990M
• Net Income: ¥634M
• EPS: ¥19.02

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a solid beat on profitability for France Bed Holdings, with revenue growth translating into stronger margins and double-digit earnings expansion. Revenue rose 4.2% YoY to 149.68bn JPY-equivalent (14.968bn yen), while operating income increased 26.6% YoY to 9.90bn JPY-equivalent, lifting operating margin to 6.6%. Ordinary income climbed 30.0% YoY to 10.28bn JPY-equivalent, and net income rose 33.0% YoY to 6.34bn JPY-equivalent. Gross margin expanded to 56.7% from 56.2% (+50 bps), supported by a favorable mix and cost control. Operating margin widened by 117 bps YoY (6.6% vs 5.4%), reflecting operating leverage as SG&A growth trailed gross profit growth. Ordinary margin improved by 136 bps (6.9% vs 5.5%) aided by higher interest/dividend income and restrained non-operating expenses. Net margin improved by 91 bps (4.2% vs 3.3%) despite a relatively high effective tax rate of 38.3%. Earnings quality within the P&L is clean: extraordinary gains were de minimis (0.02) and non-operating income was modest relative to sales. Balance sheet strength remains a key positive with a current ratio of 253.5% and interest coverage of 52.1x. Leverage is conservative with debt/capital at 11.4% and cash covering short-term debt by 4.7x. Segment-wise, both Medical Services and Home Furnishing & Health posted revenue and profit growth, with segment profits up 15.9% and 73.1% YoY respectively, and overall segment profit advancing to 1,049 million yen. ROE calculated by DuPont is 1.6% for the quarter, supported by margin expansion but constrained by low asset turnover. Guidance implies full-year EPS of 92 yen and DPS of 42 yen (payout ~46%), and Q1 progress on profit is slightly behind the 25% run-rate. Working capital intensity remains an overhang, evidenced by long DSO/DIO and CCC quality alerts. Overall, the quarter supports the full-year trajectory on margins, but working capital efficiency is the swing factor for cash generation and progress towards guidance.

Profitability Analysis

Decomposing ROE via DuPont: ROE = Net Profit Margin (4.2%) × Asset Turnover (0.220) × Financial Leverage (1.71x) ≈ 1.6%. The largest positive change came from margins: operating margin improved to 6.6% (+117 bps YoY), driving better net margin (+91 bps). Asset turnover remains low at 0.220, reflecting a balance sheet with sizable current and fixed assets relative to quarterly sales. The improvement in operating margin appears driven by higher gross profit (GP +5.1% YoY to 84.81) outpacing SG&A growth (+2.8% to 74.90), indicating operating leverage and disciplined cost control. Non-operating items were a slight tailwind (interest burden >1.0 due to net non-operating income), but the effect is modest relative to operating gains. The tax burden (0.616) is heavier than the >0.70 benchmark, muting ROE uplift. The margin gains look sustainable near-term given segment profit traction in both Medical Services (745m, margin ~7.5%) and Home Furnishing & Health (303m, margin ~6.2%), though seasonality and mix could create quarterly variability. A watchpoint is if SG&A growth re-accelerates faster than revenue; currently, SG&A grew slower than revenue, a positive spread supporting operating leverage.

Growth Assessment

Revenue grew 4.2% YoY to 149.68, with broad-based gains: Medical Services +3.3% to 99.25 and Home Furnishing & Health +5.6% to 49.40. Operating income rose 26.6% YoY to 9.90, and ordinary income increased 30.0% to 10.28, evidencing improved efficiency and cost discipline. Net income advanced 33.0% YoY to 6.34, aided by higher gross profit and modest non-operating tailwinds. Segment profits increased to 745m (Medical Services) and 303m (Home Furnishing & Health), up 15.9% and 73.1% YoY respectively, highlighting both core rental/medical equipment momentum and improved profitability in furnishings/health products. Margin expansion across gross (+50 bps), operating (+117 bps), ordinary (+136 bps), and net (+91 bps) points to healthier mix and fixed-cost absorption. The quarter sets a constructive tone for the year, but sustained execution in Home Furnishing & Health and continued rental fleet utilization in Medical Services are key to maintaining the margin profile. Working capital intensity remains the primary governor of cash-backed growth.

Financial Health

Liquidity is strong: current ratio 253.5% and quick ratio 212.2% comfortably exceed benchmarks. Interest-bearing debt totals 51.25 against equity of 398.84, with debt/capital at 11.4% and D/E (reported) 0.71x, indicating a conservative capital structure. Interest coverage is robust at 52.1x, reflecting ample EBIT relative to interest expense. Maturity profile presents low mismatch risk: short-term loans of 15.40 are covered 4.7x by cash (72.55), and current assets (361.48) significantly exceed current liabilities (142.62). Accounts payable (21.87) and electronically recorded obligations (9.91) are modest relative to receivables and inventory, implying reliance on internal liquidity rather than supplier credit. Asset retirement obligations total 3.52 and are incorporated on-balance; no off-balance sheet obligations are indicated. Notably, goodwill declined 26.1% YoY under JGAAP amortization, slightly reducing impairment risk concentration.

Notable B/S Changes

Goodwill: -0.58 (-26.1%) - Decline consistent with JGAAP amortization; reduces future impairment concentration.

Cash Flow Quality

While operating cash flow is not disclosed, balance sheet movements suggest seasonal outflows in Q1: income taxes payable declined (339 to 99), and provision for bonuses decreased (1.705 to 0.861), consistent with bonus and tax payments. Receivables decreased YoY (97.96 to 84.88), a positive for cash conversion, while inventories increased (54.76 to 58.78), reflecting continued working capital intensity. With cash/short-term debt at 4.71x and low leverage, near-term liquidity for dividends and routine capex appears manageable. Sustained improvement in inventory turnover and receivables collection would be the key drivers to enhance cash conversion.

Dividend Sustainability

Guided DPS is 42 yen versus EPS of 92 yen, implying a payout ratio of approximately 46%, within a sustainable range. Strong liquidity (current ratio 253.5%) and low debt burden (debt/capital 11.4%) support dividend capacity. Interest coverage of 52.1x reduces financing risk to distributions. Progress toward earnings guidance (Q1 EPS 19.02) is modestly below the 25% run-rate, but margin momentum provides a buffer. Continued attention to working capital efficiency will be important to ensure dividends are covered by free cash flow as the year progresses.

Risk Assessment

Business risks include Segment concentration: Medical Services contributes 66.1% of revenue, increasing dependency on healthcare rental/medical products demand and reimbursement frameworks., Inventory intensity: Elevated DIO indicates risk of obsolescence and carrying costs if demand softens., Execution risk in Home Furnishing & Health: Sustaining recent profit uplift requires continued mix/pricing discipline..

Financial risks include Working capital cycle risk: Long CCC (574 days) ties up cash and can pressure OCF in slower quarters., High receivable days (207) raises collection and credit risk, particularly with healthcare institutions., Tax burden (effective tax rate 38.3%) structurally dampens net profitability versus operating performance..

Key concerns include ⚠️ CAPITAL_EFFICIENCY: ROIC 1.6% (<5%). Root cause: low asset turnover against a large asset base in rental-heavy operations; Context: below manufacturing benchmarks; Impact: constrains valuation multiples and long-term compounding unless asset efficiency improves., ⚠️ HIGH_RECEIVABLE_DAYS: DSO 207 days (>60). Root cause: extended billing/collection cycles in medical rental and institutional customers; Context: elevated versus industry norms; Impact: liquidity drag and potential credit cost risk., ⚠️ HIGH_INVENTORY_DAYS: DIO 490 days (>90). Root cause: broad SKU base and rental fleet/finished goods holding; Context: far above benchmarks; Impact: cash tied up, risk of markdowns/obsolescence., ⚠️ LONG_CCC: Cash conversion cycle 574 days (>120). Root cause: combination of high DSO and DIO with modest DPO; Context: structurally long cycle; Impact: higher working capital needs and sensitivity of OCF to sales swings., ⚠️ HIGH_INVENTORY_DAYS: 331 days (>60). Root cause: alternative calculation still indicates elevated inventory duration; Context: consistently high regardless of method; Impact: underscores urgency of inventory discipline..

Investment Implications

Key takeaways include Margin-led beat: Operating margin expanded 117 bps YoY to 6.6% with broad segment profit growth., Balance sheet strength: Current ratio 253% and interest coverage 52x provide resilience., Capital efficiency challenge: ROIC/ROE constrained by low asset turnover., Working capital intensity: Very long DSO/DIO/CCC is the main overhang on cash conversion., Guidance tracking: Q1 profit progress is modestly below the 25% run-rate, requiring stronger back-half execution..

Metrics to watch include Inventory days and turnover by category (medical rental fleet, beds/furnishings), DSO trend and receivable aging, Segment profit margins (Medical Services vs Home Furnishing & Health), Operating cash flow and FCF coverage of dividends, Tax rate trajectory and any structural planning benefits.

Regarding relative positioning, Within Japan’s healthcare equipment/rental and furnishings niche, France Bed combines defensive end-market exposure with conservative leverage and improving margins, but lags peers on capital efficiency and cash conversion due to structurally long working capital cycles.